Annual FCF
-$14.12 M
-$7.82 M-124.25%
September 30, 2024
Summary
- As of February 12, 2025, APDN annual free cash flow is -$14.12 million, with the most recent change of -$7.82 million (-124.25%) on September 30, 2024.
- During the last 3 years, APDN annual FCF has risen by +$1.82 million (+11.40%).
Performance
APDN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.62 M
-$103.80 K-2.95%
September 30, 2024
Summary
- As of February 12, 2025, APDN quarterly free cash flow is -$3.62 million, with the most recent change of -$103.80 thousand (-2.95%) on September 30, 2024.
- Over the past year, APDN quarterly FCF has dropped by -$395.50 thousand (-12.26%).
- APDN quarterly FCF is now -2362.69% below its all-time high of $160.00 thousand, reached on March 31, 2023.
Performance
APDN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$14.12 M
-$1.08 M-8.27%
September 30, 2024
Summary
- As of February 12, 2025, APDN TTM free cash flow is -$14.12 million, with the most recent change of -$1.08 million (-8.27%) on September 30, 2024.
- Over the past year, APDN TTM FCF has dropped by -$3.06 million (-27.71%).
Performance
APDN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
APDN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -124.3% | -12.3% | -27.7% |
| 3 y3 years | +11.4% | -2362.7% | -86.9% |
| 5 y5 years | -103.8% | -2362.7% | -86.9% |
APDN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -124.3% | +11.4% | -2362.7% | +4.9% | -124.3% | +7.5% |
| 5 y | 5-year | -124.3% | +11.4% | -2362.7% | +35.6% | -124.3% | +11.4% |
| alltime | all time | <-9999.0% | +11.4% | -2362.7% | +35.6% | <-9999.0% | +11.4% |
Applied DNA Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$14.12 M(+124.3%) | -$3.62 M(+3.0%) | -$14.12 M(+8.3%) |
| Jun 2024 | - | -$3.52 M(+9.0%) | -$13.04 M(+18.0%) |
| Mar 2024 | - | -$3.22 M(-14.2%) | -$11.06 M(+44.1%) |
| Dec 2023 | - | -$3.76 M(+47.8%) | -$7.67 M(+21.8%) |
| Sep 2023 | -$6.30 M(-33.5%) | -$2.54 M(+66.0%) | -$6.30 M(-13.2%) |
| Jun 2023 | - | -$1.53 M(-1056.9%) | -$7.26 M(-4.0%) |
| Mar 2023 | - | $160.00 K(-106.7%) | -$7.56 M(-6.1%) |
| Dec 2022 | - | -$2.38 M(-31.9%) | -$8.04 M(-15.0%) |
| Sep 2022 | -$9.47 M(-40.6%) | -$3.50 M(+91.2%) | -$9.47 M(-18.3%) |
| Jun 2022 | - | -$1.83 M(+459.3%) | -$11.58 M(+0.7%) |
| Mar 2022 | - | -$327.40 K(-91.4%) | -$11.51 M(-24.6%) |
| Dec 2021 | - | -$3.81 M(-32.2%) | -$15.26 M(-4.3%) |
| Sep 2021 | -$15.94 M(+30.6%) | -$5.62 M(+220.6%) | -$15.94 M(+11.4%) |
| Jun 2021 | - | -$1.75 M(-57.0%) | -$14.31 M(-8.1%) |
| Mar 2021 | - | -$4.08 M(-9.0%) | -$15.58 M(+11.6%) |
| Dec 2020 | - | -$4.49 M(+12.4%) | -$13.96 M(+14.4%) |
| Sep 2020 | -$12.21 M(+76.2%) | -$3.99 M(+32.1%) | -$12.21 M(+22.2%) |
| Jun 2020 | - | -$3.02 M(+22.5%) | -$9.99 M(+21.0%) |
| Mar 2020 | - | -$2.46 M(-9.8%) | -$8.26 M(+2.0%) |
| Dec 2019 | - | -$2.73 M(+53.8%) | -$8.09 M(+16.8%) |
| Sep 2019 | -$6.93 M(-3.5%) | -$1.78 M(+37.9%) | -$6.93 M(-9.5%) |
| Jun 2019 | - | -$1.29 M(-44.0%) | -$7.66 M(+1.2%) |
| Mar 2019 | - | -$2.30 M(+46.9%) | -$7.57 M(+23.5%) |
| Dec 2018 | - | -$1.57 M(-37.5%) | -$6.13 M(-14.7%) |
| Sep 2018 | -$7.18 M(-5.8%) | -$2.51 M(+109.7%) | -$7.18 M(+27.7%) |
| Jun 2018 | - | -$1.19 M(+38.6%) | -$5.63 M(-10.9%) |
| Mar 2018 | - | -$862.10 K(-67.1%) | -$6.32 M(-22.4%) |
| Dec 2017 | - | -$2.62 M(+176.5%) | -$8.13 M(+6.7%) |
| Sep 2017 | -$7.62 M(-28.6%) | -$948.00 K(-49.7%) | -$7.62 M(-17.8%) |
| Jun 2017 | - | -$1.88 M(-29.7%) | -$9.27 M(-8.1%) |
| Mar 2017 | - | -$2.68 M(+27.0%) | -$10.09 M(+0.8%) |
| Dec 2016 | - | -$2.11 M(-18.6%) | -$10.01 M(-6.3%) |
| Sep 2016 | -$10.68 M(+40.5%) | -$2.59 M(-3.9%) | -$10.68 M(+6.8%) |
| Jun 2016 | - | -$2.70 M(+3.7%) | -$10.01 M(+13.8%) |
| Mar 2016 | - | -$2.60 M(-6.6%) | -$8.79 M(+9.4%) |
| Dec 2015 | - | -$2.79 M(+45.3%) | -$8.04 M(+5.7%) |
| Sep 2015 | -$7.60 M(-13.0%) | -$1.92 M(+29.4%) | -$7.60 M(-4.1%) |
| Jun 2015 | - | -$1.48 M(-19.8%) | -$7.93 M(-6.2%) |
| Mar 2015 | - | -$1.85 M(-21.5%) | -$8.45 M(-3.9%) |
| Dec 2014 | - | -$2.36 M(+5.1%) | -$8.80 M(+3.4%) |
| Sep 2014 | -$8.74 M(+2.8%) | -$2.24 M(+11.6%) | -$8.51 M(-4.0%) |
| Jun 2014 | - | -$2.01 M(-8.5%) | -$8.87 M(+0.2%) |
| Mar 2014 | - | -$2.20 M(+6.3%) | -$8.85 M(+0.2%) |
| Dec 2013 | - | -$2.07 M(-20.4%) | -$8.83 M(+3.8%) |
| Sep 2013 | -$8.51 M(+106.3%) | -$2.60 M(+30.4%) | -$8.51 M(+21.5%) |
| Jun 2013 | - | -$1.99 M(-8.6%) | -$7.00 M(+13.8%) |
| Mar 2013 | - | -$2.18 M(+25.2%) | -$6.15 M(+21.8%) |
| Dec 2012 | - | -$1.74 M(+59.7%) | -$5.05 M(+22.5%) |
| Sep 2012 | -$4.12 M | -$1.09 M(-4.7%) | -$4.12 M(-10.3%) |
| Jun 2012 | - | -$1.14 M(+5.9%) | -$4.59 M(+10.4%) |
| Mar 2012 | - | -$1.08 M(+33.0%) | -$4.16 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | -$811.50 K(-48.0%) | -$4.10 M(+9.1%) |
| Sep 2011 | -$3.85 M(+56.8%) | -$1.56 M(+119.8%) | -$3.76 M(+20.3%) |
| Jun 2011 | - | -$710.30 K(-30.4%) | -$3.13 M(+5.9%) |
| Mar 2011 | - | -$1.02 M(+117.2%) | -$2.95 M(+26.2%) |
| Dec 2010 | - | -$469.80 K(-49.3%) | -$2.34 M(-4.8%) |
| Sep 2010 | -$2.46 M(-0.5%) | -$926.40 K(+73.2%) | -$2.46 M(+13.6%) |
| Jun 2010 | - | -$534.90 K(+31.4%) | -$2.16 M(-3.5%) |
| Mar 2010 | - | -$407.10 K(-30.6%) | -$2.24 M(-9.3%) |
| Dec 2009 | - | -$586.80 K(-7.2%) | -$2.47 M(+0.1%) |
| Sep 2009 | -$2.47 M(-16.3%) | -$632.10 K(+2.9%) | -$2.47 M(+2.3%) |
| Jun 2009 | - | -$614.40 K(-3.5%) | -$2.41 M(+10.8%) |
| Mar 2009 | - | -$636.90 K(+8.8%) | -$2.18 M(+3.6%) |
| Dec 2008 | - | -$585.30 K(+1.6%) | -$2.10 M(-28.7%) |
| Sep 2008 | -$2.95 M(+30.3%) | -$576.20 K(+52.2%) | -$2.95 M(-0.6%) |
| Jun 2008 | - | -$378.60 K(-32.6%) | -$2.97 M(-5.2%) |
| Mar 2008 | - | -$561.90 K(-60.8%) | -$3.13 M(+0.3%) |
| Dec 2007 | - | -$1.43 M(+140.8%) | -$3.12 M(+38.0%) |
| Sep 2007 | -$2.26 M(-25.8%) | -$594.60 K(+9.5%) | -$2.26 M(-4.7%) |
| Jun 2007 | - | -$543.00 K(-1.8%) | -$2.37 M(-22.1%) |
| Mar 2007 | - | -$552.80 K(-3.4%) | -$3.05 M(-4.8%) |
| Dec 2006 | - | -$572.20 K(-18.9%) | -$3.20 M(+4.9%) |
| Sep 2006 | -$3.05 M(-66.7%) | -$705.90 K(-41.9%) | -$3.05 M(-12.8%) |
| Jun 2006 | - | -$1.21 M(+72.4%) | -$3.50 M(-29.5%) |
| Mar 2006 | - | -$704.90 K(+66.7%) | -$4.96 M(-37.8%) |
| Dec 2005 | - | -$422.80 K(-63.3%) | -$7.98 M(-12.8%) |
| Sep 2005 | -$9.14 M(+195.1%) | -$1.15 M(-56.9%) | -$9.14 M(+3.7%) |
| Jun 2005 | - | -$2.68 M(-28.0%) | -$8.82 M(+33.6%) |
| Mar 2005 | - | -$3.72 M(+133.9%) | -$6.60 M(+88.1%) |
| Dec 2004 | - | -$1.59 M(+91.5%) | -$3.51 M(+13.3%) |
| Sep 2004 | -$3.10 M(+530.4%) | -$830.70 K(+81.0%) | -$3.10 M(+18.4%) |
| Jun 2004 | - | -$459.00 K(-27.0%) | -$2.62 M(+16.5%) |
| Mar 2004 | - | -$628.40 K(-46.8%) | -$2.25 M(+34.9%) |
| Dec 2003 | - | -$1.18 M(+237.0%) | -$1.66 M(+238.7%) |
| Sep 2003 | -$491.50 K(+4864.6%) | -$350.20 K(+299.3%) | -$491.50 K(+247.8%) |
| Jun 2003 | - | -$87.70 K(+87.8%) | -$141.30 K(+163.6%) |
| Mar 2003 | - | -$46.70 K(+576.8%) | -$53.60 K(+676.8%) |
| Dec 2002 | - | -$6900.00(<-9900.0%) | -$6900.00(-30.3%) |
| Dec 2001 | -$9900.00(+2375.0%) | $0.00(-100.0%) | -$9900.00(-3.9%) |
| Sep 2001 | - | -$9900.00(<-9900.0%) | -$10.30 K(+2475.0%) |
| Jun 2001 | - | $0.00(0.0%) | -$400.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) | -$400.00(0.0%) |
| Dec 2000 | -$400.00(-91.3%) | -$400.00(<-9900.0%) | -$400.00(-91.3%) |
| Sep 2000 | - | $0.00(0.0%) | -$4600.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | -$4600.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | -$4600.00(0.0%) |
| Dec 1999 | -$4600.00(+53.3%) | -$4600.00(<-9900.0%) | -$4600.00(<-9900.0%) |
| Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00 | $0.00 |
| Dec 1998 | -$3000.00(<-9900.0%) | - | - |
| Dec 1997 | $0.00 | - | - |
FAQ
- What is Applied DNA Sciences annual free cash flow?
- What is the all time high annual FCF for Applied DNA Sciences?
- What is Applied DNA Sciences annual FCF year-on-year change?
- What is Applied DNA Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Applied DNA Sciences?
- What is Applied DNA Sciences quarterly FCF year-on-year change?
- What is Applied DNA Sciences TTM free cash flow?
- What is the all time high TTM FCF for Applied DNA Sciences?
- What is Applied DNA Sciences TTM FCF year-on-year change?
What is Applied DNA Sciences annual free cash flow?
The current annual FCF of APDN is -$14.12 M
What is the all time high annual FCF for Applied DNA Sciences?
Applied DNA Sciences all-time high annual free cash flow is $0.00
What is Applied DNA Sciences annual FCF year-on-year change?
Over the past year, APDN annual free cash flow has changed by -$7.82 M (-124.25%)
What is Applied DNA Sciences quarterly free cash flow?
The current quarterly FCF of APDN is -$3.62 M
What is the all time high quarterly FCF for Applied DNA Sciences?
Applied DNA Sciences all-time high quarterly free cash flow is $160.00 K
What is Applied DNA Sciences quarterly FCF year-on-year change?
Over the past year, APDN quarterly free cash flow has changed by -$395.50 K (-12.26%)
What is Applied DNA Sciences TTM free cash flow?
The current TTM FCF of APDN is -$14.12 M
What is the all time high TTM FCF for Applied DNA Sciences?
Applied DNA Sciences all-time high TTM free cash flow is $0.00
What is Applied DNA Sciences TTM FCF year-on-year change?
Over the past year, APDN TTM free cash flow has changed by -$3.06 M (-27.71%)